isocoumarins has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldemir, H; Gulder, TAM; Imhoff, JF; Schmaljohann, R; Wiese, J | 1 |
| Agata, N; Hirokoshi, K; Ichinose, K; Kinomura, M; Kitayama, H; Maeshima, Y; Makino, H; Sugiyama, H; Takazawa, Y; Yamamoto, Y; Yamasaki, Y | 1 |
2 other study(ies) available for isocoumarins and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Asperentin B, a New Inhibitor of the Protein Tyrosine Phosphatase 1B.
Topics: Aspergillus; Cell Line, Tumor; Diabetes Mellitus, Type 2; Enzyme Inhibitors; HT29 Cells; Humans; Insulin; Isocoumarins; Mediterranean Sea; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Signal Transduction | 2017 |
2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
Topics: Angiogenesis Inhibitors; Animals; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Heart; Insulin; Interleukin-6; Isocoumarins; Kidney; Liver; Mice; Obesity; Organ Size; Placebos; Polymerase Chain Reaction; Transforming Growth Factor beta | 2006 |